Overactive Bladder - Results from #200

Persistence in percutaneous tibial nerve stimulation treatment for overactive bladder syndrome is best predicted by patient global impression of improvement rather than symptom-specific improvement. January 3, 2021

The Effect of Social Determinants of Health on Overactive Bladder Symptom Severity. December 27, 2020

[Follow-up and evaluation of non-neurogenic OAB treatments]. December 27, 2020

The impact of overactive bladder on health-related quality of life in Korea: based on the results of a Korean Community Health Survey. December 27, 2020

Do Older Adults with Overactive Bladder Demonstrate Impaired Executive Function Compared to Their Peers Without OAB? December 20, 2020

Vibegron Improves Quality-of-Life Measures in Patients With Overactive Bladder: Patient-Reported Outcomes From the EMPOWUR Study. December 20, 2020

Evaluating the Quality of Overactive Bladder Patient Education Material on YouTube: A Pilot Study Using the Patient Education Materials Assessment Tool. December 13, 2020

Urodynamic predictors of de novo overactive bladder after single-incision sling. December 13, 2020

A retrospective longitudinal evaluation of new overactive bladder patients in an FPMRS urologist practice: Are patients following up and utilizing third-line therapies? December 13, 2020

Which Drugs Are Best for Overactive Bladder? From Patients' Expectations to Physicians' Decisions. December 6, 2020

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity. December 6, 2020

Mirabegron Add-On Therapy to Tamsulosin in Men with Overactive Bladder: Post Hoc Analyses of Efficacy from the MATCH Study. November 29, 2020

[First-line treatment for non-neurogenic overactive bladder]. November 29, 2020

Shifting the treatment paradigm in idiopathic overactive bladder. November 22, 2020

Prevalence and bother of lower urinary tract symptoms and overactive bladder in Poland, an Eastern European Study. November 22, 2020

Persistence and Adherence of Anticholinergics and Beta-3 Agonist for the Treatment of Overactive Bladder: Systematic Review and Meta-Analysis, and Network Meta-Analysis. November 22, 2020

Urovant Sciences Announces Positive Clinical Efficacy and Safety Data from Vibegron EMPOWUR Long Term Extension Study November 19, 2020

A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder. November 15, 2020

Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012-2016. November 15, 2020

The Correlation between Severity of Overactive Bladder Symptoms with Female Sexual Dysfunction and Sexual Satisfaction of Partners. November 15, 2020

Page 11 of 102

email news signup